ERPUSA's announcement of a fully stocked USA warehouse is facing immediate pushback after a community member pointed out that HCG — a product the vendor has long pledged to carry — is still absent from its offerings. 'Still don't see HCG, which has long been promised,' wrote a community member in an 11-post thread, framing the launch claim against a visible gap between marketing and shelf reality. "Still don't see HCG - which has long been promised - so I'm still hella," wrote a community member, framing the launch announcement against a gap between marketing and shelf reality.
The vendor's representative engaged, but redirected the question to a private messaging channel rather than addressing the stock question in-thread. "Everything seems normal to me," wrote a community member Linda, asking the buyer to make contact off-thread. That move is not itself a red flag — most peptide transactions and CoA handoffs occur off-thread — but it leaves the publicly surfaced concern about HCG availability unresolved for the broader audience reading the thread.
“Fully stocked? Still don't see HCG - which has long been promised - so I'm still hella.”
Engagement is modest and steady: 2,000 views against 10 replies and just 5 unique participants over the captured posts, with the posting arc flat from first quarter to last. The thread surfaces a specific, checkable discrepancy rather than diffuse FUD; the broader subject-area window is down 38% versus prior, a contraction worth noting for anyone calibrating lane activity.